Stanford University

Grantee website Palo Alto, California, United States
Purpose
to evaluate the safety and efficacy of the CRISPR-Cas13 system with the goal of enabling a pre-clinical animal study to test this modality in non-human primates
Division
Global Health
Date
OCTOBER 2021
Region served
GLOBAL
Committed amount
$1,235,112
Grant topic
Discovery and Translational Sciences
Duration (months)
23
Grantee location
Palo Alto, California, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.